| PERIOD ENDING | 28-Feb-09 | 1-Mar-08 | 3-Mar-07 | | Total Revenue | 45,015,000 | 40,023,000 | 35,934,000 | | Cost of Revenue | 34,017,000 | 30,477,000 | 27,165,000 | | | Gross Profit | 10,998,000 | 9,546,000 | 8,769,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 8,984,000 | 7,385,000 | 6,770,000 | | Non Recurring | 144,000 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,870,000 | 2,161,000 | 1,999,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (76,000) | 129,000 | 131,000 | | Earnings Before Interest And Taxes | 1,794,000 | 2,290,000 | 2,130,000 | | Interest Expense | 94,000 | 62,000 |
-
| | Income Before Tax | 1,700,000 | 2,228,000 | 2,130,000 | | Income Tax Expense | 674,000 | 815,000 | 752,000 | | Minority Interest | (30,000) | (3,000) | (1,000) | | | | Net Income From Continuing Ops | 1,003,000 | 1,407,000 | 1,377,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 1,003,000 | 1,407,000 | 1,377,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,003,000 | $1,407,000 | $1,377,000 |
|
1.48% Nasdaq 
Income Statement
